Clinical Trials for To Evaluate the Efficacy of Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Colorectal Carcinoma

Find clinical trials for to evaluate the efficacy of fruquintinib and pirfenidone in combination with anti-pd-1 antibody in colorectal carcinoma. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma

NCT ID: NCT06484153

This clinical trial is studying the effectiveness and safety of a combination treatment using two drugs, fruquintinib and pirfenidone, along with an anti-PD-1 antibody for patients with advanced co...

Not yet recruiting

Phase: PHASE1 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions